Iomed Inc.

Myrexis, a biotech company developing small molecule compounds with novel chemical structures and distinct mechanisms of action, has decided to keep its interim president and CEO, Robert Lollini, in p

Mary Stuart Anyone who’s prone to sea sickness can appreciate the marvel of transdermal drug delivery. When keeping ones’ eyes focused on the horizon doesn’t quell the queasy feeling that comes with m

Diabetes Devices Developments in Continuous Glucose Monitoring Continuous glucose monitoring has been the watchword in the diabetes device industry for several years now, but this technology represent

Anyone who’s prone to sea sickness can appreciate the marvel of transdermal drug delivery. When keeping ones’ eyes focused on the horizon doesn’t quell the queasy feeling that comes with motion sickne